Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Clinical trial NCT01833520 · COMPLETED
Trial details
- NCT number
- NCT01833520
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-16
- Primary completion
- 2020-04-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.